Methylprednisolone Dosing in Autoimmune Encephalitis
For the treatment of autoimmune encephalitis, methylprednisolone should be administered at a dose of 1 g IV daily for 3-5 days, followed by an oral corticosteroid taper. 1
Initial Treatment Approach
Mild to Moderate Autoimmune Encephalitis
- Initial treatment with methylprednisolone 1-2 mg/kg/day IV 1
- If symptoms are progressing or not improving, escalate to pulse dose therapy 1
Severe or Progressive Autoimmune Encephalitis
- Administer pulse dose methylprednisolone 1 g IV daily for 3-5 days 1
- This high-dose regimen is particularly indicated when:
Adjunctive Therapies
- Consider adding intravenous immunoglobulin (IVIG) 2 g/kg divided over 5 days in severe cases 1
- For refractory cases or those with confirmed autoimmune encephalopathy antibodies, consider:
Special Considerations
Transverse Myelitis Variant
- For autoimmune encephalitis with transverse myelitis features, consider:
Post-Treatment Management
- Following high-dose IV methylprednisolone, transition to oral corticosteroid taper 1
- Typical taper duration is 4-6 weeks 2
- Monitor closely for symptom recurrence during taper 1
Administration Considerations
- High-dose methylprednisolone (>0.5 g) should be administered over at least 30 minutes to avoid cardiac arrhythmias 3
- For severe cases requiring repeated dosing, administration may be repeated every 4-6 hours for up to 48-72 hours 3
Monitoring and Follow-up
- Neurologic consultation should be obtained for all cases of autoimmune encephalitis 1
- Regular clinical assessment for treatment response is essential 1
- Be vigilant for relapse, particularly when tapering corticosteroids 1, 4
Pitfalls and Caveats
- Exclude infectious causes (particularly viral) before initiating high-dose corticosteroids 1
- Consider empiric antiviral therapy (IV acyclovir) until CSF results are available 1
- Rapid administration of high-dose methylprednisolone (>0.5 g over <10 minutes) has been associated with cardiac arrhythmias 3
- Prolonged corticosteroid therapy (≥3 months) without maintenance immunotherapy may be sufficient for some forms of autoimmune encephalitis (e.g., anti-LGI1), but this approach requires careful monitoring 4